We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+11.95%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.41B
AUM Growth
+$131M
Cap. Flow
-$472M
Cap. Flow %
-10.71%
Top 10 Hldgs %
31.99%
Holding
983
New
316
Increased
242
Reduced
174
Closed
237

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$145M
2
AMGN icon
Amgen
AMGN
+$84.8M
3
PRGO icon
Perrigo
PRGO
+$60.8M
4
THC icon
Tenet Healthcare
THC
+$53.5M
5
CAH icon
Cardinal Health
CAH
+$41.2M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$132M
2
ENDP
Endo International plc
ENDP
+$80.9M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$65M
4
ESRX
Express Scripts Holding Company
ESRX
+$65M
5
GILD icon
Gilead Sciences
GILD
+$51.3M

Sector Composition

Rank Sector Weight
1 Healthcare 52.02%
2 Consumer Staples 4.24%
3 Consumer Discretionary 4.22%
4 Industrials 3.96%
5 Utilities 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIRX
51
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$20.5M 0.46%
19,656
+260
+1% +$278K
NBIX icon
52
Neurocrine Biosciences
NBIX
$16.8B
$20.5M 0.46%
1,807,137
-141,083
-7% -$1.94M
PEP icon
53
PepsiCo
PEP
$190B
$19.8M 0.45%
248,757
+139,465
+128% +$11.5M
HUM icon
54
Humana
HUM
$43.7B
$19M 0.43%
+203,414
New +$18.7M
NUS icon
55
Nu Skin
NUS
$252M
$19M 0.43%
197,983
+92,439
+88% +$7.84M
ZTS icon
56
Zoetis
ZTS
$32.4B
$17.7M 0.4%
569,327
+101,333
+22% +$3.1M
SRE icon
57
Sempra
SRE
$57.9B
$17.6M 0.4%
411,298
+111,838
+37% +$4.75M
JNJ icon
58
Johnson & Johnson
JNJ
$618B
$16.2M 0.37%
186,879
-510,795
-73% -$45.8M
IWM icon
59
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$16M 0.36%
1,500
-173,500
-99% -$17.9M
AME icon
60
Ametek
AME
$55.4B
$15.8M 0.36%
344,366
+306,796
+817% +$13.8M
BEAM
61
DELISTED
BEAM INC COM STK (DE)
BEAM
$15.3M 0.35%
236,468
+75,963
+47% +$4.88M
FEIC
62
DELISTED
FEI COMPANY
FEIC
$14.1M 0.32%
160,375
+69,161
+76% +$5.5M
LIFE
63
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
$14M 0.32%
186,815
+58,887
+46% +$4.39M
MCD icon
64
McDonald's
MCD
$192B
$14M 0.32%
145,221
-112,056
-44% -$10.9M
ARIA
65
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$13.9M 0.31%
+754,156
New +$14.6M
CXT icon
66
Crane NXT
CXT
$2.99B
$13.4M 0.3%
625,040
+317,724
+103% +$6.75M
BAX icon
67
Baxter International
BAX
$13.5B
$12.1M 0.28%
340,079
-203,276
-37% -$7.89M
MDT icon
68
Medtronic
MDT
$109B
$12.1M 0.27%
226,627
+211,615
+1,410% +$11.4M
FLNA
69
Filana Therapeutics
FLNA
$48.8M
$11.8M 0.27%
621,429
– –
MOH icon
70
Molina Healthcare
MOH
$10.2B
$11.6M 0.26%
+325,400
New +$12M
MNTA
71
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11.5M 0.26%
800,000
-4,250,000
-84% -$65M
LBTYK icon
72
Liberty Global Class C
LBTYK
$3.53B
$11.3M 0.26%
369,400
+118,566
+47% +$3.56M
ABT icon
73
Abbott
ABT
$183B
$10.9M 0.25%
327,292
+108,933
+50% +$3.82M
HOLX
74
CALL
DELISTED
Hologic
HOLX
$10.3M 0.23%
+5,000
New +$106K
GNMK
75
DELISTED
GenMark Diagnostics, Inc
GNMK
$9.48M 0.22%
+780,444
New +$8.37M
1 2
3
4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q3 2013 Portfolio in Review

As of Q3 2013, Visium Asset Management held 983 positions worth $4.41B, up 3.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management withdrew a net $472M in Q3 2013, closing 237 positions and reducing 174 holdings. Its most notable exit was Bausch Health, an estimated $132M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Visium Asset Management opened a new position in Brookdale Senior Living worth $37.5M.

  • Visium Asset Management's largest Q3 2013 buy was Brookdale Senior Living: 1,426,060 shares worth $37.5M.
  • Visium Asset Management added most to Allergan Inc in Q3 2013, an estimated $145M increase.
  • Visium Asset Management's biggest Q3 2013 reduction was Endo International plc, cutting an estimated $80.9M.
  • Visium Asset Management fully exited Bausch Health in Q3 2013, selling an estimated $132M.
  • Visium Asset Management's ten largest holdings make up 32% of its $4.41B portfolio in Q3 2013.
  • Visium Asset Management opened 316 new positions and closed 237 in Q3 2013.
  • Visium Asset Management's portfolio value rose 3.1% quarter-over-quarter to $4.41B.

Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.